
ABOUT US
We are dedicated to realizing the potential of natural killer (NK) cells for the treatment of cancer. Our proprietary technology is designed to harness the power of these important pathogen-fighting immune cells and is uniquely capable of enhancing their ability to search and destroy tumor cells.

Off the shelf Allogenic Platform
Recognising the potential of cell therapy by enhancing a key type of immune cell, Natural Killer (NK) cells, with new properties to create transformative cancer treatments for more patients. Using synthetic biology and non-viral cell engineering, it is possible to develop a highly potent allogeneic, off-the-shelf chimeric antigen receptor (CAR)-NK cell therapies capable of treating challenging cancers, including solid tumors, by combining new functional attributes with the inherent cancer-fighting properties of NK cells.
OUR
VISION
To bring curative allogenic cell therapies to India & ROW at the same time as the US & Europe


OUR
MISSION
To ensure early, affordable and quality access to curative cell therapies to patients in India
& ROW

HARNSESSING THE POWER OF NK-CELL FOR CANCER TREATMENT
Off the shelf
Allogenic Platform
Recognising the potential of cell therapy by enhancing a key type of immune cell, Natural Killer (NK) cells, with new properties to create transformative cancer treatments for more patients. Using synthetic biology and non-viral cell engineering, it is possible to develop a highly potent allogeneic, off-the-shelf chimeric antigen receptor (CAR)-NK cell therapies capable of treating challenging cancers, including solid tumors, by combining new functional attributes with the inherent cancer-fighting properties of NK cells.


OUR VIRAL VECTOR PLATFORM
Platform to support broad range of virus types. GMP production services using both transient transfection and stable packaging cell-line-based processes.Support production of vectors with either adherent or suspension-based platforms.

Director & Co-founder
Dr. (Maj) Dinesh Kundu
(MBBS, MBA)

-
15 years of experience in Biotech & Healthcare Delivery.
-
MBBS, MBA (ISB & LBS)
-
Core expertise – Business Strategy & Clinical Strategy
-
Global Clinical Trials and launch planning of E.Coli

Director & Co-founder
Mitul Agarwal
B. Pharma, MBA

-
20 years of experience in Biotech & Plasma Baxter, Fresenius, Intas
-
Core expertise – Business Development, Sales, in-licensing
-
Global & India new product launches Launch & pricing strategies

Director & Co-founder
Dr. Renu Kundu
MDS, PhD

-
Experience of devising Regulatory Strategy for Filings in DCGI and ROW markets.
-
Coordination with CROs for the pre-clinical and clinical trials.

Director & Co-founder
Dr. Narinder Mehra
PhD, Post Doc Immunogenetics

-
Pioneer of Transplant Immunology and Immunogenetics in India.
-
India’s top Science Award winner – Bhatnagar Prize & more than 100 awards.
-
Founding member and fellow of leading global Societies.
-
Advisor to Indian FDA and Govt on establishing regulations.